• Predictive Oncology joins race to develop Covid-19 vaccine pharmaceutical-technology
    May 18, 2020
    Predictive Oncology has joined the race to develop a Covid-19 vaccine with the acquisition of Soluble Therapeutics, followed by collaboration and licensing of a new nanoparticle vaccine technology platform.
PharmaSources Customer Service